Anticoagulation for the treatment of thrombotic complications in patients with cirrhosis

Liver International

Volumn 32, Issue 10, 2012, Pages 1465-1476

  Rodriguez Castro, Kryssia I ^a   Simioni, Paolo ^a   Burra, Patrizia ^a   Senzolo, Marco ^a  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

Author keywords

Anticoagulation; Cirrhosis; Deep vein thrombosis; Portal vein thrombosis; Pulmonary embolism

Indexed keywords

ANTIVITAMIN K; ENOXAPARIN; FONDAPARINUX; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; NADROPARIN;

ANTICOAGULATION; BLEEDING; CLINICAL FEATURE; DEEP VEIN THROMBOSIS; DRUG EFFECT; DRUG EFFICACY; HEPARIN INDUCED THROMBOCYTOPENIA; HUMAN; LIVER CIRRHOSIS; LOW DRUG DOSE; LUNG EMBOLISM; PATHOPHYSIOLOGY; PORTAL VEIN THROMBOSIS; REVIEW; RISK FACTOR; SYMPTOM; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; HEPARIN; HUMANS; INCIDENCE; LIVER CIRRHOSIS; LIVER TRANSPLANTATION; PREVALENCE; RISK FACTORS; VENOUS THROMBOSIS; VITAMIN K;

EID: 84867096209     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2012.02839.x     Document Type: Review

References (87)

1. Lisman T, Caldwell SH, Burroughs AK, et al. Hemostasis and thrombosis in patients with liver disease: the ups and downs. J Hepatol 2010; 53: 362-71.
2. Senzolo M, Burroughs AK Hemostasis alterations in liver disease and liver transplantation. In: Kitchens G, Alving B, Kessler G, eds. Consultative Hemostasis and Thrombosis. Philadelphia, PA: Saunders, 2007; 490-502.
3. Aldawood A, Arabi Y, Aljumah A, et al. The incidence of venous thromboembolism and practice of deep venous thrombosis prophylaxis in hospitalized cirrhotic patients. Thromb J 2011; 9: 1.
4. Zocco MA, Di SE, De CR, et al. Thrombotic risk factors in patients with liver cirrhosis: correlation with MELD scoring system and portal vein thrombosis development. J Hepatol 2009; 51: 682-9.
5. Francoz C, Belghiti J, Vilgrain V, et al. Splanchnic vein thrombosis in candidates for liver transplantation: usefulness of screening and anticoagulation. Gut 2005; 54: 691-7.
6. Rajani R, Bjornsson E, Bergquist A, et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 2010; 32: 1154-62.
7. Nonami T, Yokoyama I, Iwatsuki S, Starzl TE The incidence of portal vein thrombosis at liver transplantation. Hepatology 1992; 16: 1195-8.
8. Ravaioli M, Zanello M, Grazi GL, et al. Portal vein thrombosis and liver transplantation: evolution during 10 years of experience at the University of Bologna. Ann Surg 2011; 253: 378-84.
9. Davidson BR, Gibson M, Dick R, Burroughs A, Rolles K Incidence, risk factors, management, and outcome of portal vein abnormalities at orthotopic liver transplantation. Transplantation 1994; 57: 1174-7.
10. Ogren M, Bergqvist D, Bjorck M, et al. Portal vein thrombosis: prevalence, patient characteristics and lifetime risk: a population study based on 23, 796 consecutive autopsies. World J Gastroenterol 2006; 12: 2115-9.
11. Cho JY, Suh KS, Shin WY, et al. Thrombosis confined to the portal vein is not a contraindication for living donor liver transplantation. World J Surg 2008; 32: 1731-7.
12. Shi LW, Verran D, Chang D, et al. Primary liver transplantation with preexisting portal vein thrombosis. Transplant Proc 2003; 35: 354-5.
13. Tripodi A, Salerno F, Chantarangkul V, et al. Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests. Hepatology 2005; 41: 553-8.
14. Tripodi A, Primignani M, Chantarangkul V, et al. An imbalance of pro- vs anti-coagulation factors in plasma from patients with cirrhosis. Gastroenterology 2009; 137: 2105-11.
15. Fimognari FL, De SA, Piccheri C, et al. Evaluation of D-dimer and factor VIII in cirrhotic patients with asymptomatic portal venous thrombosis. J Lab Clin Med 2005; 146: 238-43.
16. Martinelli I von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis. Semin Hematol 2005; 42: 49-55.
17. Martinelli I, Primignani M, Aghemo A, et al. High levels of factor VIII and risk of extra-hepatic portal vein obstruction. J Hepatol 2009; 50: 916-22.
18. Amitrano L, Brancaccio V, Guardascione MA, et al. Inherited coagulation disorders in cirrhotic patients with portal vein thrombosis. Hepatology 2000; 31: 345-8.
19. Amitrano L, Guardascione MA, Brancaccio V, et al. Risk factors and clinical presentation of portal vein thrombosis in patients with liver cirrhosis. J Hepatol 2004; 40: 736-41.
20. Mangia A, Villani MR, Cappucci G, et al. Causes of portal venous thrombosis in cirrhotic patients: the role of genetic and acquired factors. Eur J Gastroenterol Hepatol 2005; 17: 745-51.
21. Llado L, Fabregat J, Castellote J, et al. Management of portal vein thrombosis in liver transplantation: influence on morbidity and mortality. Clin Transplant 2007; 21: 716-21.
22. Cherqui D, Duvoux C, Rahmouni A, et al. Orthotopic liver transplantation in the presence of partial or total portal vein thrombosis: problems in diagnosis and management. World J Surg 1993; 17: 669-74.
23. Yerdel MA, Gunson B, Mirza D, et al. Portal vein thrombosis in adults undergoing liver transplantation: risk factors, screening, management, and outcome. Transplantation 2000; 69: 1873-81.
24. Englesbe MJ, Schaubel DE, Cai S, Guidinger MK, Merion RM Portal vein thrombosis and liver transplant survival benefit. Liver Transpl 2010; 16: 999-1005.
25. Pan C, Shi Y, Zhang JJ, et al. Single-center experience of 253 portal vein thrombosis patients undergoing liver transplantation in China. Transplant Proc 2009; 41: 3761-5.
26. Englesbe MJ, Kubus J, Muhammad W, et al. Portal vein thrombosis and survival in patients with cirrhosis. Liver Transpl 2010; 16: 83-90.
27. Senzolo M, Sartori M, Rossetto V, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic portosistemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012; 32: 919-27.
28. D'Amico G, de FR Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38: 599-612.
29. Ferreira CN, Rodrigues T, Alexandrino P, Ramalho F, Velosa JF Portal vein thrombosis in cirrhotic patients is associated with advanced liver disease and predicts poor long term prognosis. Hepatology 2010; 52: 1072A.
30. Vianna R, Giovanardi RO, Fridell JA, Tector AJ Multivisceral transplantation for diffuse portomesenteric thrombosis in a patient with life-threatening esophagogastroduodenal bleeding. Transplantation 2005; 80: 534-5.
31. Lendoire J, Raffin G, Cejas N, et al. Liver transplantation in adult patients with portal vein thrombosis: risk factors, management and outcome. HPB (Oxford) 2007; 9: 352-6.
32. Borchert DH Cavoportal hemitransposition for the simultaneous thrombosis of the caval and portal systems - a review of the literature. Ann Hepatol 2008; 7: 200-11.
33. Selvaggi G, Weppler D, Nishida S, et al. Ten-year experience in porto-caval hemitransposition for liver transplantation in the presence of portal vein thrombosis. Am J Transplant 2007; 7: 454-60.
34. Doenecke A, Tsui TY, Zuelke C, et al. Pre-existent portal vein thrombosis in liver transplantation: influence of pre-operative disease severity. Clin Transplant 2010; 24: 48-55.
35. Bertelli R, Nardo B, Montalti R, et al. Liver transplantation in recipients with portal vein thrombosis: experience of a single transplant center. Transplant Proc 2005; 37: 1119-21.
36. Dumortier J, Czyglik O, Poncet G, et al. Eversion thrombectomy for portal vein thrombosis during liver transplantation. Am J Transplant 2002; 2: 934-8.
37. Gayowski TJ, Marino IR, Doyle HR, et al. A high incidence of native portal vein thrombosis in veterans undergoing liver transplantation. J Surg Res 1996; 60: 333-8.
38. Molmenti EP, Roodhouse TW, Molmenti H, et al. Thrombendvenectomy for organized portal vein thrombosis at the time of liver transplantation. Ann Surg 2002; 235: 292-6.
39. Suarez AG, Barrera PL, Alamo Martinez JM, et al. Outcomes of liver transplantation in candidates with portal vein thrombosis. Transplant Proc 2010; 42: 3156-8.
40. Shi Z, Yan L, Zhao J, et al. Prevention and treatment of rethrombosis after liver transplantation with an implantable pump of the portal vein. Liver Transpl 2010; 16: 324-31.
41. Tao YF, Teng F, Wang ZX, et al. Liver transplant recipients with portal vein thrombosis: a single center retrospective study. Hepatobiliary Pancreat Dis Int 2009; 8: 34-9.
42. Gimeno FA, Calvo J, Loinaz C, et al. Comparative analysis of the results of orthotopic liver transplantation in patients with and without portal vein thrombosis. Transplant Proc 2005; 37: 3899-903.
43. Figueras J, Torras J, Rafecas A, et al. Extra-anatomic venous graft for portal vein thrombosis in liver transplantation. Transpl Int 1997; 10: 407-8.
44. Lerut JP, Mazza D, van Leeuw V, et al. Adult liver transplantation and abnormalities of splanchnic veins: experience in 53 patients. Transpl Int 1997; 10: 125-32.
45. Egawa H, Tanaka K, Kasahara M, et al. Single center experience of 39 patients with preoperative portal vein thrombosis among 404 adult living donor liver transplantations. Liver Transpl 2006; 12: 1512-8.
46. Azoulay D, Adam R, Castaing D, et al. Liver transplantation with cavoportal or renoportal anastomosis: a solution in cases of diffuse portal thrombosis. Gastroenterol Clin Biol 2002; 26: 325-30.
47. Manzanet G, Sanjuan F, Orbis P, et al. Liver transplantation in patients with portal vein thrombosis. Liver Transpl 2001; 7: 125-31.
48. De SA, Moscatelli R, Catalano C, et al. Systemic thrombolysis of portal vein thrombosis in cirrhotic patients: a pilot study. Dig Liver Dis 2010; 42: 451-5.
49. Wu H, Nguyen GC Liver cirrhosis is associated with venous thromboembolism among hospitalized patients in a nationwide US study. Clin Gastroenterol Hepatol 2010; 8: 800-5.
50. Sogaard KK, Horvath-Puho E, Gronbaek H, et al. Risk of venous thromboembolism in patients with liver disease: a nationwide population-based case-control study. Am J Gastroenterol 2009; 104: 96-101.
51. Heit JA, Silverstein MD, Mohr DN, et al. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000; 160: 809-15.
52. Huerta C, Johansson S, Wallander MA, Garcia Rodriguez LA Risk factors and short-term mortality of venous thromboembolism diagnosed in the primary care setting in the United Kingdom. Arch Intern Med 2007; 167: 935-43.
53. Dabbagh O, Oza A, Prakash S, Sunna R, Saettele TM Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease. Chest 2010; 137: 1145-9.
54. Northup PG, McMahon MM, Ruhl AP, et al. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism. Am J Gastroenterol 2006; 101: 1524-8.
55. Garcia-Fuster MJ, Abdilla N, Fabia MJ, et al. Venous thromboembolism and liver cirrhosis. Rev Esp Enferm Dig 2008; 100: 259-62.
56. Bezeaud A, Denninger MH, Dondero F, et al. Hypercoagulability after partial liver resection. Thromb Haemost 2007; 98: 1252-6.
57. Gulley D, Teal E, Suvannasankha A, Chalasani N, Liangpunsakul S Deep vein thrombosis and pulmonary embolism in cirrhosis patients. Dig Dis Sci 2008; 53: 3012-7.
58. Lesmana CR, Inggriani S, Cahyadinata L, Lesmana LA Deep vein thrombosis in patients with advanced liver cirrhosis: a rare condition? Hepatol Int 2010; 4: 433-8.
59. Stieber AC, Zetti G, Todo S, et al. The spectrum of portal vein thrombosis in liver transplantation. Ann Surg 1991; 213: 199-206.
60. Agarwal S, Senzolo M, Zappoli P, et al. Evidence of reduced fibrinolysis and blood transfusion requirements in cholestatic liver disease patients during liver transplantation (OLT). Liver Transpl 2006; 12: C2.
61. Ben-Ari Z, Panagou M, Patch D, et al. Hypercoagulability in patients with primary biliary cirrhosis and primary sclerosing cholangitis evaluated by thrombelastography. J Hepatol 1997; 26: 554-9.
62. Plessier A, Darwish-Murad S, Hernandez-Guerra M, et al. Acute portal vein thrombosis unrelated to cirrhosis: a prospective multicenter follow-up study. Hepatology 2010; 51: 210-8.
63. Amitrano L, Guardascione MA, Scaglione M, et al. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses. Am J Gastroenterol 2007; 102: 2464-70.
64. Amitrano L, Guardascione MA, Menchise A, et al. Safety and efficacy of anticoagulation therapy with low molecular weight heparin for portal vein thrombosis in patients with liver cirrhosis. J Clin Gastroenterol 2010; 44: 448-51.
65. Delgado MG, Seijo S, Yepes I, et al. Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis. Clin Gastroenterol Hepatol 2012; 10: 776-83.
66. Villa E, Zecchini R, Marietta M, et al. Enoxaparin prevents portal vein thrombosis (Pvt) and decompensation in advanced cirrhotic patients: final report of a prospective randomized controlled study. Hepatology 2011; 54: 418A-9A.
67. Kahn SR, Lim W, Dunn AS, et al. Prevention of VTE in nonsurgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 2012; 141(2 Suppl.): e195S-226S.
68. Decousus H, Tapson VF, Bergmann JF, et al. Factors at admission associated with bleeding risk in medical patients: findings from the IMPROVE investigators. Chest 2011; 139: 69-79.
69. Nevens F, Bustami R, Scheys I, Lesaffre E, Fevery J Variceal pressure is a factor predicting the risk of a first variceal bleeding: a prospective cohort study in cirrhotic patients. Hepatology 1998; 27: 15-9.
70. Brigden ML, Kay C, Le A, Graydon C, McLeod B Audit of the frequency and clinical response to excessive oral anticoagulation in an out-patient population. Am J Hematol 1998; 59: 22-7.
71. Landefeld CS, Cook EF, Flatley M, Weisberg M, Goldman L Identification and preliminary validation of predictors of major bleeding in hospitalized patients starting anticoagulant therapy. Am J Med 1987; 82: 703-13.
72. Triantos C, Vlachogiannakos J, Armonis A, et al. Primary prophylaxis of variceal bleeding in cirrhotics unable to take beta-blockers: a randomized trial of ligation. Aliment Pharmacol Ther 2005; 21: 1435-43.
73. Robert A, Chazouilleres O Prothrombin time in liver failure: time, ratio, activity percentage, or international normalized ratio? Hepatology 1996; 24: 1392-4.
74. Trotter JF, Olson J, Lefkowitz J, et al. Changes in international normalized ratio (INR) and model for endstage liver disease (MELD) based on selection of clinical laboratory. Am J Transplant 2007; 7: 1624-8.
75. Tripodi A, Chantarangkul V, Primignani M, et al. The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation. Hepatology 2007; 46: 520-7.
76. Tripodi A, Chantarangkul V, Mannucci PM The international normalized ratio to prioritize patients for liver transplantation: problems and possible solutions. J Thromb Haemost 2008; 6: 243-8.
77. Bellest L, Eschwege V, Poupon R, Chazouilleres O, Robert A A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology. Hepatology 2007; 46: 528-34.
78. Bechmann LP, Sichau M, Wichert M, et al. Low-molecular-weight heparin in patients with advanced cirrhosis. Liver Int 2011; 31: 75-82.
79. Lisman T, Porte RJ Towards a rational use of low-molecular-weight heparin in patients with cirrhosis. Liver Int 2011; 31: 1063.
80. Lehman CM, Rettmann JA, Wilson LW, Markewitz BA Comparative performance of three anti-factor Xa heparin assays in patients in a medical intensive care unit receiving intravenous, unfractionated heparin. Am J Clin Pathol 2006; 126: 416-21.
81. Rodriguez KI, Rossetto V, Radu C, et al. Effect of low molecular weight heparin on thrombin generation in cirrhotic patients. Transpl Int 2011; 24: 143-4 2012.
82. Lee CJ, Ansell JE Direct thrombin inhibitors. Br J Clin Pharmacol 2011; 72: 581-92.
83. Gross PL, Weitz JI New anticoagulants for treatment of venous thromboembolism. Arterioscler Thromb Vasc Biol 2008; 28: 380-6.
84. Ceulemans B, Aerts R, Monbaliu D, et al. Liver transplantation using cavoportal transposition: an effective treatment in patients with complete splanchnic venous thrombosis. Transplant Proc 2005; 37: 1112-4.
85. Urbani L, Cioni R, Catalano G, et al. Cavoportal hemitransposition: patient selection criteria and outcome. Transplant Proc 2002; 34: 3331-3.
86. Olausson M, Norrby J, Mjörnstedt L, et al. Liver transplantation using cavoportal hemitransposition-a life-saving procedure in the presence of extensive portal vein thrombosis. Transplant Proc 2001; 33: 1327-8.
87. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci 2011; 56: 2152-9.